SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival

Expression of the solute carrier (SLC) transporter SLC22A3 gene is associated with overall survival of pancreatic cancer patients. This study tested whether genetic variability in SLC22A3 associates with pancreatic cancer risk and prognosis. Twenty four single nucleotide polymorphisms (SNPs) tagging...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohelnikova-Duchonova, Beatrice, Strouhal, Ondrej, Hughes, David J., Holcatova, Ivana, Oliverius, Martin, Kala, Zdenek, Campa, Daniele, Rizzato, Cosmeri, Canzian, Federico, Pezzilli, Raffaele, Talar-Wojnarowska, Renata, Malecka-Panas, Ewa, Sperti, Cosimo, Federico Zambon, Carlo, Pedrazzoli, Sergio, Fogar, Paola, Milanetto, Anna Caterina, Capurso, Gabriele, Delle Fave, Gianfranco, Valente, Roberto, Gazouli, Maria, Malleo, Giuseppe, Teresa Lawlor, Rita, Strobel, Oliver, Hackert, Thilo, Giese, Nathalia, Vodicka, Pavel, Vodickova, Ludmila, Landi, Stefano, Tavano, Francesca, Gioffreda, Domenica, Piepoli, Ada, Pazienza, Valerio, Mambrini, Andrea, Pedata, Mariangela, Cantore, Maurizio, Bambi, Franco, Ermini, Stefano, Funel, Niccola, Lemstrova, Radmila, Soucek, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341046/
https://www.ncbi.nlm.nih.gov/pubmed/28272475
http://dx.doi.org/10.1038/srep43812

Ejemplares similares

Ejemplares similares